Skip to content

GSK189075

DRUG11 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2ObesityRenal InsufficiencyType 2 Diabetes Mellitus

Phase 1

Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
CompletedNCT00494767
GlaxoSmithKlineDiabetes Mellitus, Type 2, Obesity
Start: 2006-09-29End: 2007-06-07Updated: 2017-08-07
A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
CompletedNCT00501462
GlaxoSmithKlineDiabetes Mellitus, Type 2, Renal Insufficiency, Type 2 Diabetes Mellitus
Start: 2007-07-31End: 2008-03-31Updated: 2012-03-19
A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
CompletedNCT00501930
GlaxoSmithKlineDiabetes Mellitus, Type 2, Type 2 Diabetes Mellitus
Start: 2007-04-30Updated: 2012-06-04
A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers
CompletedNCT00501397
GlaxoSmithKlineDiabetes Mellitus, Type 2, Type 2 Diabetes Mellitus
Start: 2007-02-28Updated: 2012-06-04
A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
CompletedNCT00504816
GlaxoSmithKlineDiabetes Mellitus, Type 2, Type 2 Diabetes Mellitus
Start: 2007-04-30End: 2008-04-30Updated: 2012-06-04
A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
CompletedNCT00519480
GlaxoSmithKlineDiabetes Mellitus, Type 2
Start: 2007-09-11End: 2008-04-01Updated: 2017-09-06
A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults
CompletedNCT00532610
GlaxoSmithKlineDiabetes Mellitus, Type 2, Type 2 Diabetes Mellitus
Start: 2007-09-30End: 2008-02-29Updated: 2012-03-19
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
CompletedNCT00625859
GlaxoSmithKlineDiabetes Mellitus, Type 2
Start: 2008-01-16End: 2008-04-10Updated: 2017-08-24

Phase 2

Related Papers